Gopsi Pharma

Pune, India Founded: 1997 • Age: 29 yrs
Manufactures pharmaceutical intermediates and derivatives for industrial use.

About Gopsi Pharma

Gopsi Pharma is a Healthcare company based in Pune (India) founded in 1997 by Baldev Prajapati. It manufactures pharmaceutical intermediates and derivatives for industrial use. It operates on a B2B model. Its Indian entity Gopsi Pharma Private Limited reported revenue of β‚Ή7.43 Cr. Gopsi Pharma offers products and services including Para Nitro Benzyl Bromide, Para Nitro Benzyl Alcohol, Para Cyano Benzyl Bromide, Para Bromo Benzyl Bromid, and Meta Cyano Benzyl Bromide. Its focus areas include Pharmaceuticals, Manufacturing and Intermediates. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.

Company details

Gopsi Pharma Pvt. Ltd. is a manufacturer of pharmaceutical derivatives, specializing in active intermediates like Para Nitro Benzyl Bromide. Based in Bharuch, Gujarat, India, they operate under ISO 9001 certification, focusing on quality control and RD. The company produces a wide range of chemicals for pharmaceutical applications, ensuring compliance with standards and customer requirements through innovative practices and responsible waste management.

  • Headquarters Pune, India
  • Founders Baldev Prajapati
  • Sectors
    Healthcare
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website gopsipharma.net
  • Legal Name Gopsi Pharma Private Limited
  • Date of Incorporation 27 Jan, 1997
  • Jurisdiction Ankleshwar, Gujarat, India
Key Metrics
  • Annual Revenue
    ₹7.43 Cr

    FY 2023 · +9% YoY

  • Net Profit
    ₹1.26 Cr

    FY 2023 · 17% margin

  • EBITDA
    ₹1.85 Cr

    FY 2023 · 25% margin

Products & Services of Gopsi Pharma

Gopsi Pharma offers a comprehensive portfolio of products and services, including Para Nitro Benzyl Bromide, Para Nitro Benzyl Alcohol, Para Cyano Benzyl Bromide, Para Bromo Benzyl Bromid, and Meta Cyano Benzyl Bromide.

Para Nitro Benzyl Bromide
Pharmaceutical Intermediate

Chemical used in drug synthesis for pharmaceutical production.

Para Nitro Benzyl Alcohol
Pharmaceutical Intermediate

Intermediate compound for various drug manufacturing processes.

Para Cyano Benzyl Bromide
Pharmaceutical Intermediate

Essential chemical in synthesizing active pharmaceutical ingredients.

Para Bromo Benzyl Bromid
Pharmaceutical Intermediate

Compound applied in pharmaceutical derivative formulations.

Meta Cyano Benzyl Bromide
Pharmaceutical Intermediate

Used as a building block in pharmaceutical chemical production.

Ortho Cyano Benzyl Bromide
Pharmaceutical Intermediate

Chemical for creating specialized pharmaceutical compounds.

Meta Nitro Benzyl Bromide
Pharmaceutical Intermediate

Intermediate for advanced drug development applications.

Board of directors of Gopsi Pharma Private Limited (Gopsi Pharma)

Gopsi Pharma Private Limited is the primary company behind Gopsi Pharma. The board of Gopsi Pharma Private Limited currently have 3 directors; the longest-serving is Baldevbhai Govindbhai Prajapati, appointed in 1997. 2 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Baldevbhai Govindbhai Prajapati
DIN 01496198
Director27 Jan 199729 yrs 9 moGopsi Pharma Private Limited
Artiben Baldevbhai Prajapati
DIN 07102109
Director18 Feb 201511 yrs 9 moGopsi Pharma Private Limited
Prajapati Vikasbhai Baldevbhai
DIN 06587730
Director18 Feb 201511 yrs 9 moGopsi Pharma Private Limited

People of Gopsi Pharma

1 people are tracked at Gopsi Pharma (1 in leadership).

NameRoleGroup
Baldev Prajapati
Founder, MDLeadership
Premium access

Complete people profiles for Gopsi Pharma

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Gopsi Pharma

Figures of Gopsi Pharma Private Limited, the primary company behind Gopsi Pharma, for FY 2023. Revenue was ₹7.43 Cr (+9% year on year). Net profit was ₹1.26 Cr (17% margin). EBITDA was ₹1.85 Cr (25% margin). Revenue has grown at a compounded annual rate of -3% over three years and +30% over five years.

  • ₹7.43 CrRevenue · FY 2023 · +9% YoY
  • ₹1.26 CrNet profit · 17% margin
  • ₹1.85 CrEBITDA · 25% margin
  • ₹9.9 LakhPaid-up capital
  • -3%Revenue CAGR, 3 years
  • +30%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Gopsi Pharma Private Limited are on its company page.

Premium access

Detailed financial statements for Gopsi Pharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Gopsi Pharma

Gopsi Pharma has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
lauruslabs.com2005Hyderabad, India$229.73M6,035
Pharmaceutical and biotechnology company
symbiotec.in2002Indore, India$61.01M1,822
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
sequent.in2002Bengaluru, India
APIs are developed and manufactured for therapeutic areas.
Premium access

Detailed similar companies of Gopsi Pharma

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Gopsi Pharma

Gopsi Pharma was founded in 1997.

Gopsi Pharma is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.

The primary company behind Gopsi Pharma, Gopsi Pharma Private Limited, reported revenue of β‚Ή7.43 Cr for FY 2023, up 9% year on year.

Gopsi Pharma Pvt. Ltd. is a manufacturer of pharmaceutical derivatives, specializing in active intermediates like Para Nitro Benzyl Bromide. Based in Bharuch, Gujarat, India, they operate under ISO 9001 certification, focusing on quality control and RD. The company produces a wide range of chemicals for pharmaceutical applications, ensuring compliance with standards and customer requirements through innovative practices and responsible waste management.

Gopsi Pharma's top competitors include Laurus Labs, Symbiotec and SeQuent.

Gopsi Pharma offers Para Nitro Benzyl Bromide, Para Nitro Benzyl Alcohol, Para Cyano Benzyl Bromide, Para Bromo Benzyl Bromid, and 3 more products and services.

Gopsi Pharma operates through Gopsi Pharma Private Limited.

The legal entities of Gopsi Pharma currently have 3 directors, including Artiben Baldevbhai Prajapati, Prajapati Vikasbhai Baldevbhai, Baldevbhai Govindbhai Prajapati.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available